(ST049) Clinical Validation of CDKN2A/B Deletions Using the TruSight Oncology 500 Assay

Saturday, November 18, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Alicia Dillard, MD (she/her/hers)

Molecular Genetics Fellow
NewYork-Presbyterian Hospital
New York, New York, United States